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Epidemiology of acute renal failure: A prospective, multicenter,
community-based study
FERNANDO Lio, JuLio PASCUAL, and THE MADRID ACUTE RENAL FAILURE STUDY GROUP1
Epidemiology of acute renal failure (ARF): A prospective, multicenter,
community-based study. There are very limited data on overall epidemi-
ology of ARF. It is crucial to know the incidence, etiology and clinical
features of ARF to promote prevention strategies and to implement
adequate resources for the management of this entity. During a nine
month period, a collaborative prospective protocol with 98 variables was
developed to assess all ARF episodes encountered in the 13 tertiary-care
hospitals in Madrid, Spain (covering 4.2 million people of over 14 years of
age). ARF was considered when a sudden rise in serum creatinine
concentration (SCr) to more than 177 mol/liter was found in patients with
normal renal function, or when the sudden rise (50% or more) was
observed in patients with previous mild-to-moderate chronic renal failure
(Scr < 264 J.Lmol/liter). Of the 748 cases of ARF studied, 665 episodes
presented in inhabitans from the Madrid area. This gives an overall
incidence of ARF of 209 cases per million population (p.m.p.; 95% CI 195
to 223). The incidence of acute tubular necrosis (ATN) was 88 cases p.m.p.
(95% CI 79 to 97), prerenal ARF 46 p.m.p (95% CI 40 to 52), acute-onset
chronic ARF 29 p.m.p. (95% CI 24 to 34), and obstructive ARF 23 p.m.p.
(95% CI 19 to 27). The mean age was 63 17 years. The most frequent
causes of ARF were ATN (45%), prerenal (21%), acute-onset chronic
renal failure (12.7%) and obstructive ARF (10%). Renal function was
normal at admission in 48% of patients who later developed ARF.
Mortality (45%) was much higher than that of the other patients admitted
(5.4%, P < 0.001). This real outcome correlated extremely well with the
expected outcome calculated through out the severity index of ARF (SI)
0.433 0.246 (mean SD). In 187 cases, mortality was attributed to
underlying disease, thus corrected mortality due to ARF was 26.7%.
Dialysis was required in 36% of patients, and was associated with a
significantly higher SI of ARF (0.57 0.23 vs. 0.35 0.19, P < 0.001) and
mortality (65.9 vs. 33.2%, P < 0.001). Mortality in patients hemodialyzed
with biocompatible synthetic membranes (N = 50) was similar to that
observed with cellulosic ones (N = 84; 66% vs. 59.5%, NS). Mortality was
higher in patients with coma, assisted respiration, hypotension, jaundice
(all P < 0.001) and oliguria (P < 0.02). This study gives, for the first time,
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the incidence of all forms of ARF in a developed country. ARF is
iatrogenically induced at a high rate by modern medicine. Prevention
strategies, particularly in the perioperative period, are needed to decrease
its impact.
The modern history of acute renal failure (ARF) began during
the air raids over London fifty years ago [1, 21. Since then, despite
thousands of published reports addressing many different aspects
of the problem, epidemiology has been almost forgotten [3—17]. In
these few reports, one can find three types of information: dialysis
needs in ARF [3, 5, 6, 10, 13—16]; ARF incidence in hospital
communities [7, 8, 11, 12]; and studies on the incidence of ARF in
a wide population [4, 9, 10, 13—17]. Few of these studies were
prospective [4, 10, 13—16], and only one extended report dealt with
the population of a wide geographic area in a developed country
[16].
We prospectively studied the adult incidence, etiology and
clinical features of ARF in Madrid, Spain, which has a population
of approximately 4 million. From those data we have drawn a
picture of ARF in the industrialized world at the end of the
twentieth century.
Methods
Design
During a nine-month period (from October 1991 through June
1992) we prospectively studied all the ARF episodes occurring in
adult patients admitted by any of the 13 tertiary-care hospitals in
Madrid.
We had previously designed a questionnaire including a num-
ber of variables. Most of them were binary variables, and some of
them were of numerical or free-text type. The questionnaire was
easy to answer. It analyzed several important parameters: identi-
fication of the hospital and the case (anonymously), demographic
questions, date of admission and discharge, usual residence of the
patient, initial location in hospital, original disease, surgical
conditions, biopsies, general etiology of the ARF episode, cause
of the acute tubular necrosis (ATN) (if this was the cause of
ARF), drugs in the case of tubulointerstitial nephritis, initial urine
output, early clinical situation at the first visit to the nephrologist,
mortality and cause of death, use of diuretics, incidence of
gastrointestinal bleeding and preventive measures, dialysis needs
and techniques, use of plasmapheresis, etc. The questionnaires
were always completed by one or two physicians in each institu-
tion. Due to the fact that the principal investigators in each
institution could be on vacation in the summertime, the prospec-
tive study was terminated at the end of June to avoid bias.
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Statistics
From November 1991 through October 1992, all the question-
naires were sent to a designated secretarial office in one of the
hospitals. The data were entered in a database (Database plus)
and then analyzed with a personal computer and a statistical
program (Statgraphics). The Student's t-test and X2 test were used
for comparison of quantitative and qualitative variables, respec-
tively. Confidence intervals for incidence rates were assessed by
reference to the Poisson distribution. Linear correlation coeffi-
cient was used to compare the individual severity index [181 with
the real outcome in each patient.
Inclusion criteria
Only patients with ARF were studied. ARF was defined as
present when a sudden rise in serum creatinine concentration
(Scr) of more than 177 tmolIliter (2 mg/dl) was found in subjects
with prior normal renal function. Patients with previously reduced
renal function (basal Sr over 3 mg/dl) suffering a deterioration
were excluded. No pseudo renal failure case was included. Con-
sequently, a patient was included only if one of these four
conditions was evident: (1) normal plasma Sr at admission; (2)
elevation of 5Cr at admission but complete recovery before
discharge, or 50% recovery if the clinical condition was suggestive
of ARF; (3) elevation of Sr at admission without the suspicion of
chronic renal failure and with normal or increased renal size
(patients with myeloma and previously deteriorated renal func-
tion and patients with hydronephrosis with cortical atrophy were
excluded); and (4) mild-to-moderate basal chronic renal failure
(5Cr < 3 mg/dl) with a sudden rise in 5Cr (50% or more).
Definitions
Acute renal failure. As previously described.
Acute tubular necrosis (A TN). When renal function did not
improve after correction of possible prerenal causes and when
hepatorenal syndrome, vascular, interstitial, glomerular and ob-
structive etiologies were excluded. A fractional excretion of
sodium greater than 2% was considered as additional evidence if
diuretics had not been used for 48 hours before.
Prerenal ARF. When etiologic treatment (usually volume reple-
tion and/or improvement of cardiac output) was rapidly successful
in restoring renal function. A fractional excretion of sodium of
less than 1% was considered as additional evidence.
Acute glomerulopathies. Inclusion of a case with this etiology
required histologic confirmation except for acute postinfectious
cases.
Acute tubulointerstitial nephritis (A TIN). If histologically dem-
onstrated or when there was a high grade of clinical suspicion.
Vasculitis. Histologic confirmation of vasculitic involvement of
the kidney or other organs was required.
Obstructive ARF. Acute obstruction of the urinary tract without
cortical atrophy.
Renal thromboembolism. Arteriographic confirmation was re-
quired. Absence of isotope uptake was also considered when the
clinical condition was highly suggestive.
Atheroembolic disease. The diagnosis required at least three of
five clinical criteria (invasive procedure or vascular surgery before
the ARF episode, livedo reticularis, hypocomplementemia, eosin-
ophilia, retinal lesions) or one clinical criterion plus histologic
confirmation (cholesterol crystals either in cutaneous or renal
biopsies). If basal 5Cr was over 3 mg/dl, the case was excluded.
Renal vein thrombosis. Ultrasonographic or phlebographic con-
firmation was required.
Hepatorenal syndrome. ARF in terminal hepatic failure, with
urinary sodium of less than 10 mEq/liter and the absence of
clinical response to diuretics and volume expansion. A prerenal
etiology was considered in the presence of maintained diuretic
response (> 48 hr).
Oliguria. Urine output of less than 400 ml/24 hr.
Etiologic groups in ATN
Surgical ATN. Increased Sr, as defined, within 72 hours of
surgery.
Nephrotoxic ATN. Increased Sr, as defined in one of five
clinical settings: (a) 24 hours following the use of radiographic
contrast media, (b) nephrotoxic agents administered for a mini-
mum of three days previously and/or detection of high plasma
levels, (c) ingestion of nephrotoxic metals (copper, cisplatinum,
etc.), (d) hemoglobinuria or myoglobinuria found in an adequate
clinical context, and (e) ingestion of other nephrotoxic substances
such as organic solvents.
Septic ATN. At least one of these conditions was present:
documented bacteremia, a known focus of infection, immune
suppression with neutropenia. Also required was at least two of
the following findings documented at the same time: rigors,
unexplained hyperventilation, unexplained sudden fall in blood
pressure, abrupt rise in temperature to more than 38°C not due to
transfusion reaction or unexplained leukocytosis of more than
15,000 per ml.
Medical A TN. Patients not included in the previous three
groups. All of them had precipitating factors, isolated or com-
bined, such as volume depletion, low cardiac output or arterial
hypotension.
An individual severity index that measured the individual
prognosis of each patient was calculated applying the equation
developed by Liaño et al [18], considering the early clinical
situation.
The incidence of ARF in Madrid (a geographical area with a
total adult population of 4,227,837) was calculated. Hospital
admissions during the study period were 200,464, and 10,768
patients died. To preserve confidentiality the data are presented
without separating the different hospitals.
Treatments
Dialysis and other treatment were given as usual in every
hospital by the patient's doctor. In our country, medical care is
covered by a National Health System, so there were no restric-
tions on access for or maintenance of any kind of treatment. No
patient was removed from dialysis along the study.
Results
Population
A total of 748 ARF episodes were studied. The mean patient
age was 64 years (range 15 to 95); 488 were males and 260
females. The mean age was similar in both genders (59 17 vs.
62 19 years). The mean age was similar for survivors (59 19,
N = 411) and nonsurvivors (61 17, N = 337). Three hundred
fifty-nine patients (48%) were over 64-years-old.
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Table 1. Etiology, mortality and incidence of acute renal failure (ARF) in the general adult population and rate of ARF for in-hospital patients
Incidence
Type of ARF
Number
of cases
Mortality
N (%)
per million
population
yearly
95%
Confidence
interval
Rate of
in-hospital
patients
Rate of
deaths in
hospital
ATN 337 202 (60) 88 79—97 1:590 1:53
Prerenal 158 56(35) 46 40—52 1:1260 1:192
Acute onset CRF 95 33 (35) 29 24—34 1:2100 1:326
Obstructivea 75 20 (27) 23 19—27 1:2600 1:538
ATTN 15 2 (13) 3.5 1.7—5.3 1:13000 —
Vascular'' 8 4 (50) 2.1 0.8—3.4 1:25000 —
Vasculitis 11 5 (45) 3.5 1.7—5.3 1:18000
Primary GN 11 1(9) 2.8 1.2—4.4 1:18000 1:1200
Secondary GN 12 3 (25) 3.5 1.7—5.3 1:16700
Cortical necrosis 1 1(100) — — — —
Other 21 10 (48) — — — —
Unknown 4 0— — — — —
Total 748 337 (45) 209 195—223 1:267 1:32
Abbreviations are: ATN, acute tubular necrosis; CRF, chronic renal failure; ATIN, acute tubulointerstitial nephritis; GN, glomerulonephritis.
aObstructive cases comprise: lithiasis (N = 9; mortality 22%); prostatic adenoma (N = 21; mortality 0%); tumoral obstruction (N 35; mortality
49%); other causes (N = 10); mortality 10%)b Vascular cases include: atheroembolic disease (N = 6; mortality 33%) and arterial thrombosis (N = 2; both of them die)
Table 2. Etiology of 95 episodes of acute-on-chronic renal failure
Disease
No. of
patients
41Acute tubular necrosis
Prerenal 26
Atheroembolic disease 4
Acute tubulointerstitial nephritis 2
Myeloma 2
Malignant hypertension 2
Vasculitis 1
Secondary glomerulonephritis 1
Tumoral obstruction 1
Sclerodermal crisis 1
Not recorded 14
Mortality
Forty-five percent of the patients died, with a similar percent-
age of males and females. Mortality was similar in both older and
younger patients (45.4% in patients > 64 years and 44.7% < 64).
Etiology and general data
The most frequent causes of ARF were: ATN (45%), prerenal
ARF (21%), acute-onset chronic renal failure (12.7%) and ob-
structive ARF (10%). The number of cases, the mortality associ-
ated with each etiology and the incidence among the adult
population in Madrid, the number of patients admitted to hospital
and the number of patients who died are summarized in Table 1.
The etiology of acute-onset of chronic renal failure is detailed
in Table 2.
Eighty-four percent of ATN cases were attributed to only one
cause. Two or more etiologies were involved in 16%.
Origin and incidence of ARF
Eighty-three patients (11.09%) came from other regions of
Spain. Seven patients came from other countries. There was no
difference in the mean duration of length of hospitalization and
ARF episode in these patients.
The 665 ARF episodes attended in inhabitants living in Madrid
during the nine months of the study were equal to an incidence of
887 ARF episodes per year among the adult population in our
community. Given that the adult population in Madrid (over 14
years) was 4,227,837 people in 1990, the estimated incidence is
209 ARF per million population per year (95% confidence
interval: 195 to 223).
A total of 200,464 admissions was recorded in Madrid during
the study period (one ARF in each 267 admissions). The inci-
dence of ATN (excluding the 41 ATN cases occurring in patients
having acute-onset chronic renal failure) was 1 in 590 admitted
patients.
ARF and hospital-related aspects
ARF episodes were observed in all hospitalization areas. Thir-
ty-four percent occurred in medical departments, 22.6% in surgi-
cal units, 27.1% in ICUs, but only 13.3% of ARF patients were
initially admitted in a nephrology department. Only 2.3% of
patients were admitted in traumatology units and 0.7% in gyne-
cology departments.
Mortality varied depending on initial location of the patient
within the hospital: ICUs 69.6%, medical 42.8%, surgical 36.3%,
and nephrology 18.1%.
Of the 748 patients with ARF, 40.5% had normal renal function
on admission and of these 50.8% died. Only 25% were admitted
with Sr > 3 mgldl. Surprisingly enough, the mortality was
significantly lower in this group (29.8%, P < 0.001). Table 3 shows
the etiology and mortality of the various ARF types, excluding
acute-onset chronic renal failure, for different serum creatinine
concentrations at admission. It can be seen how the different ATN
forms associated with the highest mortality rate are more frequent
in hospital acquired ARF, whereas obstructive ARF, which is
associated with a low mortality rate, is mainly found in community
acquired ARF. The highest rate of mortality in patients having
normal renal function is associated with both a more serious
original disease and the necessity of a more difficult therapeutic
procedure, usually major surgery. 5Cr at admission was signifi-
cantly higher in patients directly admitted to a nephrology unit
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Se
Cause of ARF 1.5
Number of cases (mortality)
rum creatinine mgldl
3 Total1.5 1—3 >
ATN 196 (63) 88 (64) 53 (40) 337 (60)
Prerenal ARF 75 (35) 50 (40) 33 (30) 158 (35)
Obstructive ARF 17 (35) 10 (40) 48 (29) 75 (27)
ATIN 12(16) — 3(0) 15(27)
Vasculitis 4(25) 4(50) 3 (66) 11(45)
Primary GN 3 (0) — 8(12) 11(9)
Secondary GN 5 (20) 4 (0) 3 (66) 12 (25)
Atheroembolia 4 (25) — 2 (50) 6 (33)
Arterial thrombosis — 1(100) 1(100) 2 (100)
Cortical necrosis 1(100) — — 1 (100)
Other 10 6 5 20 (47)
Total 327 (51) 163 (52) 159 (32) 649 (47)
Abbreviations are: ARF, acute renal failure; ATN, acute tubular
necrosis; ATIN, acute tubulointerstitial nephritis; GN, glomerulonephri-
tis.
than in patients initially admitted to other areas (6.53 4.41
mgldl vs. 2.43 2.66 mg/dl, P < 0.001).
Two hundred ninety-seven patients (39.7%) required surgical
procedures during hospitalization and 148 of them (49.8%) died.
In 202 cases, ARF was postoperative. Fifty patients required
another operation.
The mean duration of ARF and of hospitalization in different
circumstances are summarized in Table 4. The time to recovery or
death expressed as an accumulation of frequencies along the time
is depicted in Figure 1. Eight out of 270 (3%) patients requiring
dialysis were finally admitted to a periodic dialysis program.
Clinical situation at the first visit
Upon the first visit 57.3% of patients were oliguric, 32.8% had
sustained hypotension, 27.8% needed assisted respiration and
18% were icteric. Normal consciousness was observed in 70% of
patients, 24.7% were sedated and 5.3% had profound coma.
Oliguria (52% vs. 35.7%, P < 0.02), sustained hypotension
(69% vs. 33.2%, P < 0.001), assisted respiration (79.8% vs. 31.6%,
P < 0.001) and icterus (66.9% vs. 40.1%, P < 0.001) were
associated with higher mortality (patients with vs. those without
the complication). On the contrary, normal consciousness was
associated with a lower mortality (30.3%, P < 0.001) than that
observed in cases with sedation (77%) or coma (92%).
Early prognosis and mortality
In the 748 cases of ARF studied the overall severity index
(0.433 0.264), which measured the expected outcome, was
similar to real mortality (45%). The correlation between esti-
mated evolution in each patient by means of the individual
severity index with the real evolution, mortality or survival, was
excellent (r = 0.4999, P < 0.00001).
Cause of death
The overall mortality was 45%. Excluding the 187 patients
whose underlying disease was included among the causes of death,
corrected mortality that might be attributed to ARF itself was
only 26.7%.
Excluding four patients whose cause of death was not recorded,
the number of possible causes of death in the 333 patients who
died was 2.2 1 (range 1 to 6). The most frequent were: shock
(N = 153), infection (N = 160), respiratory disease (N = 74),
heart disease (N = 50), DIC (N = 21), gastrointestinal hemor-
rhage (N = 15), peridialysis (N = 12), stroke (N = 9), other causes
(N = 56). Among the other causes were five patients who died
after withdrawal of treatment in the setting of an irreversible
condition. One patient committed suicide.
Renal biopsy
A total number of 46 biopsies were undertaken in ARF
patients, one for every 16 cases. Four were performed after
acute-onset chronic renal failure. Only 10 out of the 13 hospitals
performed the procedure, one did 12 biopsies and another
hospital did 11 pathological studies. Histological results are
detailed in Table 5.
Dialysis
Two hundred seventy patients (36%) needed dialysis. In gen-
eral only one technique was used in each patient, but in 19 cases
two techniques were used and three were used in another case.
Conventional hemodialysis was the most frequent (60.1%), fol-
lowed by continuous extracorporeal circulation techniques
(CECT; 33.1%), peritoneal dialysis (5.4%) and conventional
isolated ultrafiltration (1%). Among hemodialyzed patients bicar-
bonate was used as a buffer in 91.1%, whereas acetate was used in
the other 8.9%.
The CECT were hemodialysis (48.4%), hemodiafiltration
(39.5%) and ultrafiltration (12.1%). Here, the venovenous tech-
nique (75%) was more commonly used than the arteriovenous
(25%).
Mortality among dialyzed patients was significantly higher than
that of non-dialyzed patients (65.9% vs. 33.2%, P < 0.001). The
severity index of the former was also significantly higher than that
of the latter (0.57 0.23 vs. 0.35 0.19, P < 0.001).
In 134 patients who received conventional hemodialysis the
type of dialysis membrane was correctly recorded (Table 6).
Mortality was similar with cellulosic and synthetic membranes.
Cellulosic non-biocompatible membranes were used in 84 pa-
tients, fifty of whom (59.5%) died. Synthetic membranes (polysul-
phone or polyacrilonitrile) were used in 50 patients, with a
mortality of 66%. As can be seen in Table 6, the severity index was
Table 3. Etiology and mortality of ARF, excluding acute-onset chronic
renal failure and 4 cases of unknown etiology, distributed in 3 groups
according to serum creatinine concentration at admission
Table 4. Duration of ARF episode and admission
Duration of Duration of
ARF Admission
days
Whole group
Nonsurvivors
Survivors
Dialyzed patients
Non-dialyzed patients
14.3 15.1 30.3 24.3
11.9 14.7a 25.4 25.5"
16.6 15.4 35.1 25.1
17.1 1821, 31.0 25.8"
12.3 12.2 29.8 23.3
Results are expressed as mean SD
"P < 0.001 with respect to survivors
h P < 0.00 1 with respect to non-dialyzed
C Not significant with respect to non-dialyzed
(I)
a)(I)
Ca0
a)
>0
U)
a)
0
U)
a)0C
a)
0
a)
a)
>
Ca
E
0
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Table 5. Histologic diagnosis in the 46 renal biopsies performed in
patients with ARF
No. of
Disease patients
Primary GN 12
Extracapilar ON 6
Acute proliferative ON 3
Endocapilar and extracapillary ON 2
Focal sclerosing ON 1
Secondary ON 6
Antiglomerular basement membrane GN 3
Acute post-infectious GN 2
Diffuse proliferative (in SLE) U
Vasculitis 10
Necrotizing 5a
Wegener Granulomatosis 3
Not specified 2
Acute tubular necrosis 4.'
Acute tubulointerstitial nephritis 4
Atheroembolic disease 2
Kidney myeloma 2.'
Cortical necrosis 1
Malignant hypertension
IgA ON + acute tubular necrosis 1
Hemolytic uremic syndrome 1
Not recorded 2
a One patient with acute-onchronic renal failure
similar between both groups of patients, as was the number of
conventional hemodialysis sessions undertaken.
Mortality in patients treated with conventional hemodialysis
was lower than in those treated with CECT (58.4% vs. 82%, P <
0.001). The severity index was also lower (0.49 0.27 vs. 0.72
0.17, P < 0.001). Mortality was similar between patients treated
with continuous hemodialysis and continuous hemofiltration
(75% vs. 83%, NS), as was the severity index (0.72 0.16 vs.
0.69 0.18, NS).
Table 6. Survival in conventional hemodialysis in 134 patients with
acute renal failure according to the type of membrane used
Cellulosic
(N=84)
Synthetic(N=50)
Survivors N (%) 34 (40.5) 17 (34)
Nonsurvivors N (%) 50 (59.5) 33 (66)
Severity index' 0.52 0.24 0.47 0.26
Number of procedures (range) 6.5 7.0 (1—34) 6.5 7.4 (1—36)
Survivors mean serum 2.12 1.98 3.23 2.47
creatinine mg/dl (range) (0.7—12.0) (1.1—10.0)
Patients with oliguria
Before dialysis N (%) 57 (68) 34 (68)
Survivors 24 (42) 9 (27)
Data are means SD. All comparisons between both groups are not
significant.
a Calculated according to the equation from Ref. 18
Eight patients (1 TTP, 1 myeloma, 1 acute GN, 1 factor VIII
immune deficient and 4 with Goodpasture's syndrome) received
plasmapheresis (3 to 24 sessions).
Discussion
This prospective study of 748 ARF cases, 665 of which occurred
in inhabitants of our autonomous region, represents the largest
epidemiologic study on the incidence of ARF in a heavily
populated region to he reported [4, 10, 13—16]. The incidence of
ARF in adults (over 14 years) in Madrid is 209 cases p.m.p. (95%
CI 195 to 223). This incidence is much higher than the 52 cases
p.m.p. reported by Eliahou et al [4] in Israel in 1965 to 66 or the
95 cases p.m.p. reported by Abraham et al [10] in Kuwait in 1984
to 1986. However, it is quite similar to the more recently
published data from Glasgow, Scotland, UK (185 p.m.p., 1986 to
1988) [15], Devon, England, UK (172 p.m.p., 1986 to 1987) [16]
and Cuenca, Spain (254 p.m.p., 1988 to 1989) [13]. These studies
include all cases occurring in a given area independently of
8 patients to
chronic
hemodialysis
100
80
60
40
20
0
1 5 10 15 20 25 30 35 40 45
Days of ARF evolution
50 55 60
Fig. 1. Evolution of ARE over time. Symbols
are: (U) survivors; () non-survivors. After 10
days of established ARF, 60% of patients who
were going to die had already died, whereas
only 46% of survivors had recovered normal
renal function. Eight out of the 270 patients
(3%) who needed dialysis entered a periodic
dialysis program.
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whether the ARF develops in the community or at the hospital. It
is worth noting that our study reports for the first time the
incidence of the different forms of ARF in a developed country
(Table 1).
When we calculated the rate of ARF cases attended at the
Madrid hospitals (including ARF generated within the hospitals
and those developed in the community) we observed that I in 267
admitted patients (0.37%) had an acute deterioration of renal
function (Table 1). Similar ARF proportions (0.22 to 1%) in
hospitalized patients have been reported [10—1 21. The importance
of ARF developing within the hospital is more variable among the
different studies. We have observed that 1.5 patients per 1,000
admitted develop ARF within the hospital. This rate is almost
identical to that reported by Abraham et al (1.3 per 1,000) in a
study similar to ours [10]. Other authors, analyzing a smaller
population during shorter periods of time, found higher rates of
ARF cases occurring in the hospital (1.9 to 4.9%) [7, 8, 11]. These
differences could be attributed to methodological variations.
Males present ARF more frequently than females (65 vs. 35%).
Similar rates are found in the ATN patients. These data are in
agreement with the percentage of males (67%) recorded from
1588 cases of ATN in 14 series in the literature [21j. We divided
our ATN population into two groups in an attempt to see if a
hormonal status (pre/post-menopause) could explain these differ-
ences. The first group comprised patients between 15 and 45 years
of age and the second group consisted of patients older than 45
years of age. The rate of females in both groups was similar (30%
vs. 33%). So, hormonal status does not seem to play a role in the
incidence of ATN in either sex and consequently, at present it is
difficult to hypothetize about the differences, although probably
they could be related to vascular causes. Male and female
mortality was similar. Advanced age is associated with a higher
incidence of ARF. In our series, 48% of ARF cases occurred in
patients over 64 years, whereas these age ranges only represent
16% of the Madrid population (P < 0.001). Similar observations
have been made by others [16, 18, 22, 231.
Acute tubular necrosis (45%), prerenal ARF (21%), acute-
onset chronic renal failure (12.7%) and obstructive ARF (10%)
were the most frequent clinical forms. This etiological distribution
is similar to the French experience reported by Kleinknecht [241
and shows a 50% decrease of prerenal ARF observed in one of
our hospitals 11 years before [251. As well as the 665 ARF cases
observed in residents of Madrid, we attended 83 additional
patients from other Spanish areas and even from foreign countries
(7 cases).
Our work illustrates the fact that ARF is a universal problem in
medical practice: (a) it occurs within the community (60%) as well
as within the hospital (40%); and (b) it develops in all areas within
the hospital, that is, medical, surgical or ICUs. As a result, any
physician may face a patient with an ARF episode independently
of his/her speciality or working place. Another important related
question is that ARF episodes generated in the hospital carry a
20% higher mortality than those developed in the community and
admitted to hospital. This is probably due to a higher proportion
of ATN (58%) and surgical operations in the first group, whereas
other etiologies with better prognosis (that is, obstructive ARF)
predominate in community-acquired ARF, as other authors have
pointed out [15, 161.
Overall mortality of ARF was 45%, a similar proportion to that
reported by other authors [18, 23—37]. On distinguishing different
etiologies of ARF, the highest mortality was observed in ATN
cases (60%), followed by vascular, vasculitis, prerenal and acute-
onset chronic renal failure (Table 1). It is noteworthy that one in
every 32 patients who died within the hospital did so in the course
of an ARF episode, a fact not hitherto published. As previously
reported [25, 35—371 the highest mortality was observed in ICUs
and the lowest in patients admitted to a nephrological unit. The
low mortality rate in nephrology services may be justified by two
facts. The first is the kind of ARF treated in the nephrological
departments (the incidence of ATN, 28%; acute-onset chronic
ARF, 22%; obstructive ARF, 17%; prerenal, 15%; glomerulone-
phritis, 10%; vasculitis, 3%; ATIN, 3%; and others, 2%) is
different than the rates observed in other hospital services (ATN,
47%; prerenal, 22%; acute-onset chronic ARF, 11%; obstructive
ARF, 9%; glomerulonephritis, 2%; vasculitis, 1%). Also, special-
ized and theoretically better initial diagnosis of the patients made
by nephrologists could explain this result, as has been suggested by
Feest, Round and Hamad [16]. This fact could be supported by
the difference between the expected outcome of the nephrological
patients (51 0.292 0.138) and their real outcome (mortality rate
of 18%).
ARF was not the cause of death in any of our patients. The
original disease was the main cause of death. Other causes were
complications that developed in the course of the ARF, mainly
shock and infections. It is of interest that if we exclude those
patients whose death was attributable to original disease from the
mortality analysis, as Kennedy et al [381 did in their series in 1973,
we would obtain a "corrected mortality." This concept would be
related to complications arising in the patients with ARF, not to
the ARF itself. Of note is the fact that the "corrected mortality"
in ARF was constant during the time: 25% in the patients of
Kennedy et al [38] and 27% in this series. Similar rates have been
published by others [25, 39]. As a result of the previous data, the
old nephrological aphorism that says "No ARF patients have ever
died because of the ARF but they have died in ARF" can now be
written as, "No ARF patients have ever died because of the ARF
but they have died in ARF as a consequence of his or her original
disease or of complications appearing in the course of the ARF."
The mean duration of ARF was 14 days, which was slightly
longer than that reported by Kjellstrand, Ebben and Davin 15
years ago [23]. With similar methodology to that developed by
these authors, we determined the evolutive curves of the patients.
Those who died did so precociously (66% during the 10 first days),
while it was necessary to reach the 16th day to achieve the same
percentage of resolved ARF in the survivors (Fig. 1). In our series,
8 patients (1% of all patients and 3% of those who needed
dialysis) did not recover renal function and went into chronic
renal replacement programs. Kjellstrand et al reported a similar
percentage [231.
Although we have not directly measured the cost of ARF, we
might estimate the cost of the assistance to a patient with ARF as
three times that of a patient without ARF, as the length of
hospitalization is three times longer.
The initial clinical situation of our patients is similar to that
usually reported [18, 24—36]. Only 40% of them were nonoliguric,
whereas 70% had a normal conciousness level, and the rest were
sedated or comatose. In agreement with other authors [18,
24—36], we observed that the presence of oliguria, sustained
hypotension, assisted respiration, jaundice, sedation or coma was
Liaño et al: Epidemiology of the acute renal failure 817
associated with significantly higher mortality despite the etiology
of ARF.
The use of our ARF-severity index [18, 191 has been very
effective in this study. The real mortality (45%) was very close to
that estimated by the index (0.43). The same can be said about the
individual severity index and correlation with the final evolution of
the patient (r = 0.499, P < 0.00001). This occurred despite the
fact that individual severity index is a continuous number, while
real evolution survival or death, may only be statistically consid-
ered as a discontinuous number. These results, obtained from the
application made by 13 different hospitals to a large number of
patients, highlight the usefulness of the index described by one of
us [18, 191.
The use of parameters to measure the severity of a group of
patients will be crucial to compare, for example, the homogeneity
of two populations [19, 401. Tn the near future, we will be able to
assess whether the severity of a disease changes with time, an
assessment which some authors have already attempted in ARF
[19, 41, 421.
We have collected a small number of renal biopsies, only 1 per
16 ARF episodes. This is not surprising if we note that in the most
important etiologic groups (ATN, prerenal and obstructive) the
diagnosis is clinical and accounts for 76% of cases. In general,
there is a tendency to restrict the use of renal biopsy in ARF
diagnosis. In fact, for a long time in Spain [31 we have reserved
the practice of renal biopsies for the following circumstances:
absence of an obvious cause for ARF, ARF of more than three
weeks duration, the presence of extrarenal manifestations com-
patible with a systemic disease, and suspicion of a parenquimatous
cause of renal failure excluding ATN.
Our results shown in Table 5 to some extent confirm this policy,
as only four cases of ATN were observed in the 46 biopsies carried
out. Nevertheless, these results do not completely rule out that
few patients having parenchymatous ARF could have been noso-
logically incorrectly classified. However, throughout the study we
have tried to avoid this bias. For instance, we have diagnosed
(only for epidemiological considerations) eight patients as having
ATTN without biopsy. All of them had previous normal renal
function, an absence of other causes of ARF, high clinical
suspicion and improvement of renal function after drug with-
drawal or worsening of renal function when a drug was restarted.
Up to 36% of our ARF episodes required dialysis, an incidence
of 57 cases p.m.p. per year, or 134:100,000 admitted patients. This
incidence is higher than that reported during the sixties [3] and
seventies [5] in industrialized countries (30 dialysis p.m.p.). More
recent data from different geographic areas show incidences
between 21 and 71 p.m.p. [10, 13—161. The need for dialysis
decreases in regions without the availability of major surgery [13,
16] and increases as this is progressively implemented; an increase
from 30 to 71 dialysis p.m.p. in two different periods (1975 to 1981
and 1988 to 1990, respectively) in the same Scottish district in
parallel with the progress in surgery, supports this notion [14].
Our data demonstrate that hemodialysis continues to be the
most frequent renal replacement therapy in ARF patients, that
bicarbonate is the preferred buffer (91%), and that continuous
extracorporeal techniques are clearly gaining importance, espe-
cially the veno-venous forms. Of interest, mortality among pa-
tients treated with continuous dialysis was higher than that
observed among patients managed with conventional hemodialy-
sis. Using Liaflo's score [18], we have demonstrated that this
difference is not due to a negative effect of the technique itself, but
to the disease severity.
We do not confirm recently published data on significantly
higher survival with biocompatible membranes in conventional
hemodialysis for ARF [44, 45]. The hypothesis in these two studies
is that the use of synthetic, biocompatible membranes will reduce
mortality of ARF. Although we recognize that our multicenter
study was not designed to explore this point, the mortality was
similar with cellulosic and synthetic membranes, with a compara-
ble severity of ARF episodes in both groups. The study published
by Schiffi et al [44] ended too early and only included a small
number of patients, and the study by Hakim, Wingard and Parker
[451 does not convincingly show an overall better survival with
synthetic polymethylmethacrylate in oliguric patients. It is clear
that the effect of dialysis membrane on survival in ARF patients is
open for further research.
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